Roufosse, C., Becker, J. U., Rabant, M., Seron, D., Bellini, M. I., Böhmig, G. A., . . . Naesens, M. (2022). Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
Citación estilo ChicagoRoufosse, Candice, et al. Proposed Definitions of Antibody-Mediated Rejection for Use As a Clinical Trial Endpoint in Kidney Transplantation. 2022.
Cita MLARoufosse, Candice, et al. Proposed Definitions of Antibody-Mediated Rejection for Use As a Clinical Trial Endpoint in Kidney Transplantation. 2022.
Precaución: Estas citas no son 100% exactas.